IGIM
IRWD icon

I.G. Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

I.G. Investment Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-53,730
Closed -$720K – 893
2015
Q1 		$720K Buy
+53,730
New +$705K ﹤0.01% 702
2014
Q1 		– Sell
-89,908
Closed -$874K – 861
2013
Q4 		$874K Buy
89,908
+48,118
+115% +$432K ﹤0.01% 605
2013
Q3 		$415K Buy
+41,790
New +$410K ﹤0.01% 720

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

I.G. Investment Management's IRWD Position: Q2 2015 in Review

I.G. Investment Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2015, closing a stake of 53,730 shares — an estimated $720K sold.

I.G. Investment Management first reported a position in IRWD in Q3 2013 and held it in 3 quarters. The position peaked at $874K in Q4 2013. 137 funds tracked by Wall St. Rank hold IRWD as of Q2 2015.

  • I.G. Investment Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • I.G. Investment Management sold 53,730 Ironwood Pharmaceuticals shares in Q2 2015, an estimated $720K.
  • I.G. Investment Management first reported a position in Ironwood Pharmaceuticals in Q3 2013 and held it in 3 quarters.
  • I.G. Investment Management's Ironwood Pharmaceuticals position peaked at $874K in Q4 2013.
  • 137 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2015.

Based on I.G. Investment Management's 13F filing for Q2 2015, filed 11 Aug 2015.